These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
779 related articles for article (PubMed ID: 32281052)
1. Mesenchymal Stem Cell Therapy for COVID-19: Present or Future. Golchin A; Seyedjafari E; Ardeshirylajimi A Stem Cell Rev Rep; 2020 Jun; 16(3):427-433. PubMed ID: 32281052 [TBL] [Abstract][Full Text] [Related]
2. Immunomodulation and Regeneration Properties of Dental Pulp Stem Cells: A Potential Therapy to Treat Coronavirus Disease 2019. Zayed M; Iohara K Cell Transplant; 2020; 29():963689720952089. PubMed ID: 32830527 [TBL] [Abstract][Full Text] [Related]
3. CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement. Ulrich H; Pillat MM Stem Cell Rev Rep; 2020 Jun; 16(3):434-440. PubMed ID: 32307653 [TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment. Jayaramayya K; Mahalaxmi I; Subramaniam MD; Raj N; Dayem AA; Lim KM; Kim SJ; An JY; Lee Y; Choi Y; Raj A; Cho SG; Vellingiri B BMB Rep; 2020 Aug; 53(8):400-412. PubMed ID: 32731913 [TBL] [Abstract][Full Text] [Related]
5. Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia. Zhang Y; Ding J; Ren S; Wang W; Yang Y; Li S; Meng M; Wu T; Liu D; Tian S; Tian H; Chen S; Zhou C Stem Cell Res Ther; 2020 May; 11(1):207. PubMed ID: 32460839 [TBL] [Abstract][Full Text] [Related]
6. Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial. Meng F; Xu R; Wang S; Xu Z; Zhang C; Li Y; Yang T; Shi L; Fu J; Jiang T; Huang L; Zhao P; Yuan X; Fan X; Zhang JY; Song J; Zhang D; Jiao Y; Liu L; Zhou C; Maeurer M; Zumla A; Shi M; Wang FS Signal Transduct Target Ther; 2020 Aug; 5(1):172. PubMed ID: 32855385 [TBL] [Abstract][Full Text] [Related]
7. Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients. Rogers CJ; Harman RJ; Bunnell BA; Schreiber MA; Xiang C; Wang FS; Santidrian AF; Minev BR J Transl Med; 2020 May; 18(1):203. PubMed ID: 32423449 [TBL] [Abstract][Full Text] [Related]
8. Challenges for Mesenchymal Stem Cell-Based Therapy for COVID-19. Li C; Zhao H; Wang B Drug Des Devel Ther; 2020; 14():3995-4001. PubMed ID: 33061304 [TBL] [Abstract][Full Text] [Related]
9. Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use. Atluri S; Manchikanti L; Hirsch JA Pain Physician; 2020 Mar; 23(2):E71-E83. PubMed ID: 32214286 [TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm. Song N; Wakimoto H; Rossignoli F; Bhere D; Ciccocioppo R; Chen KS; Khalsa JK; Mastrolia I; Samarelli AV; Dominici M; Shah K Stem Cells; 2021 Jun; 39(6):707-722. PubMed ID: 33586320 [TBL] [Abstract][Full Text] [Related]
11. Mesenchymal Stem Cells: A New Piece in the Puzzle of COVID-19 Treatment. Saldanha-Araujo F; Melgaço Garcez E; Silva-Carvalho AE; Carvalho JL Front Immunol; 2020; 11():1563. PubMed ID: 32719683 [TBL] [Abstract][Full Text] [Related]
12. The Disillusioned Comfort with COVID-19 and the Potential of Convalescent Plasma and Cell Therapy. Borlongan MC; Borlongan MC; Sanberg PR Cell Transplant; 2020; 29():963689720940719. PubMed ID: 32841042 [TBL] [Abstract][Full Text] [Related]
13. Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients. Al-Khawaga S; Abdelalim EM Stem Cell Res Ther; 2020 Oct; 11(1):437. PubMed ID: 33059757 [TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cell immunomodulation and regeneration therapeutics as an ameliorative approach for COVID-19 pandemics. Yadav P; Vats R; Bano A; Bhardwaj R Life Sci; 2020 Dec; 263():118588. PubMed ID: 33049279 [TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cell research progress for the treatment of COVID-19. Yao D; Ye H; Huo Z; Wu L; Wei S J Int Med Res; 2020 Sep; 48(9):300060520955063. PubMed ID: 32972277 [TBL] [Abstract][Full Text] [Related]
16. MSCs transplantation may be a potential therapeutic strategy for COVID-19 treatment. Wang XY Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4537-4538. PubMed ID: 32373992 [TBL] [Abstract][Full Text] [Related]
17. Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy - Achieving global consensus and visibility for cellular host-directed therapies. Zumla A; Wang FS; Ippolito G; Petrosillo N; Agrati C; Azhar EI; Chang C; El-Kafrawy SA; Osman M; Zitvogel L; Galle PR; Locatelli F; Gorman E; Cordon-Cardo C; O'Kane C; McAuley D; Maeurer M Int J Infect Dis; 2020 Jul; 96():431-439. PubMed ID: 32425638 [TBL] [Abstract][Full Text] [Related]
18. The use of mesenchymal stromal cells in the treatment of coronavirus disease 2019. Canham MA; Campbell JDM; Mountford JC J Transl Med; 2020 Sep; 18(1):359. PubMed ID: 32958009 [TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics. Qin H; Zhao A Protein Cell; 2020 Oct; 11(10):707-722. PubMed ID: 32519302 [TBL] [Abstract][Full Text] [Related]
20. Extracellular vesicles from mesenchymal stem cells as a Covid-19 treatment. O'Driscoll L Drug Discov Today; 2020 Jul; 25(7):1124-1125. PubMed ID: 32387262 [No Abstract] [Full Text] [Related] [Next] [New Search]